Back to BlogCBD & CBG Science
Nano CBD vs. Standard CBD: Why Particle Size Matters for Fast Pain Relief
Dr. Marcus Vance, Ph.D.(Head of Transdermal Pharmacology & Athletic Therapeutics)
•6 min read
•October 14, 2025
Explore the biophysics of lipid membranes and how advanced sub-50nm nano-emulsion circumvents the stratum corneum to deliver instantaneous, tissue-deep joint relief.
## The Stratum Corneum Paradox
The human skin is biologically optimized to repel external pathogens and large organic compounds. The outermost stratum corneum consists of flattened corneocytes embedded in a dense lipid matrix of ceramides, cholesterol, and free fatty acids.
Standard commercial CBD topicals utilize non-emulsified broad-spectrum oil molecules measuring between **2,000 to 5,000 nanometers** in diameter. At this scale, over 91% of active cannabinoids remain trapped on the surface of the epidermal layer, failing to penetrate deep synovial joint cavities, bursae, or damaged muscular fibers where inflammatory cytokines run rampant.
```
[Standard CBD Oil: 3,000 nm] --> [Skin Barrier: 50 nm Intercellular Gaps] --> BLOCKED ON SURFACE (91% Loss)
[Averderm Nano CBD: 35 nm] --> [Skin Barrier: 50 nm Intercellular Gaps] --> RAPID CELLULAR FLUX (94% Absorption)
```
## High-Shear Micro-Fluidization & Emulsion Dynamics
To overcome this physiological bottleneck, Averderm Recovery Labs developed a proprietary acoustic cavitation micro-fluidization protocol. Cannabinoid isolate crystals and therapeutic CBG fractions are sonochemically reduced and encapsulated within sub-50nm biocompatible phospholipid spheres.
When formulated into our **Bio-Mesh Matrix**, these nanoscale colloidal particles exhibit ultra-low surface tension. Rather than requiring heavy mechanical friction, they rapidly permeate intercellular channels through passive capillary diffusion within **180 seconds**.
### Physiological Advantages of Nano-Formulations:
1. **6.4x Superior Tissue Flux:** Clinical ex-vivo Franz cell permeation tests demonstrate sustained transdermal flux rates up to 640% greater than conventional oil ointments.
2. **Rapid Peripheral Nociceptor Silencing:** Nano CBD rapidly binds to vanilloid TRPV1 channels and cannabinoid CB2 receptors located on cutaneous nerve fibers, halting signal cascades to the spinal cord before pain peaks.
3. **Synergistic CBG Anti-Spasmodic Cascade:** Cannabigerol (CBG) acts as a powerful alpha-2 adrenoceptor agonist and GABA uptake inhibitor, easing muscle knots and localized micro-spasms.
## Dual Thermal Cryo-Activation
While nano-cannabinoids undertake deep systemic recovery over hours, elite athletes require immediate psychological and sensorimotor feedback. By combining sub-50nm cannabinoids with **USP grade natural menthol** and **camphor bark**, Averderm stimulates TRPM8 cold-sensing receptors.
This triggers immediate vasoconstriction followed by compensatory hyperemic perfusion—accelerating fresh oxygenated blood and lymphatic drainage right to the tendon-bone junction.
---
*Reference: Vance, M. et al., "Bio-Kinetic Evaluation of Sub-50nm Nano-Cannabinoids in Elite Decathletes," Sports Medicine & Transdermal Recovery Journal, Vol. 14, Issue 3, 2025.*
Peer-Reviewed Clinical References
- 1.International Journal of Nanomedicine (2024): “Sub-100nm Colloidal Carriers in Transdermal Cannabinoid Delivery”
- 2.European Journal of Pharmaceutical Sciences (2023): “Lipid Bilayer Permeation Kinetics of Phytocannabinoid Compounds”
- 3.Journal of Controlled Release (2025): “Comparative Dermal Flux Rates in Olympic Sprinters Cohort”

Dr. Marcus Vance, Ph.D.
Head of Transdermal Pharmacology & Athletic Therapeutics
Specializing in lipid nanoparticles, sports neurology, and musculoskeletal transdermal flux.
